Report cover image

Global Prostate Cancer Diagnostics Market Size & Share to 2027

Publisher QualiKet Research
Published Apr 29, 2022
Length 189 Pages
SKU # QUA17148460

Description

Global Prostate Cancer Diagnostics Market Size & Share to 2027

Global Prostate Cancer Diagnostics Market Size, Trends & Growth Opportunity, By Type (Benign Prostatic Hyperplasia, Prostatic Adenocarcinoma, Small Cell Carcinoma, and Others), By Diagnosis (Tissue Biopsy, Transrectal Ultrasound, Clinical Laboratory Examination, Urine Testing, and Prostate Specific Antigen Testing), By Treatment, By Region and Forecast till 2027

Global Prostate Cancer Diagnostics Market

Prostate gland is situated in the pelvis below the bladder. Prostate cancer is the medical condition which is an unbounded and unusual growth of cells in the prostate glands of the male. Growth of healthcare expenditure and innovation of new technologies in minimally invasive surgeries to patients due to early post-operative recovery are also likely to driven the global prostate cancer diagnostics market growth.

Market Drivers

Rise in prevalence of prostate cancer is key driving factor which is expected boost the global prostate cancer diagnostics market growth. For instant, as per the National Cancer Institute in United State around 174,650 new cases were diagnosed in year 2019. Furthermore, growing technological advancements in diagnostic tests are expected to further propel the global prostate cancer diagnostics market growth over the forecast period. Also, increase in government support and initiatives to develop new technologies to enhance diagnosis will positively influence the market growth. The increase in number of number of new market entrants is another driving factor anticipated to drive the market growth in near future. In addition to that, increase in product approvals by USFDA is projected to support the global prostate cancer diagnostics market growth.

Market Restraints

The high cost of prostate cancer drugs is the major restrain which is expected to hinder the global prostate cancer diagnostics market growth. Also, low success rate of clinical trials will affect the global prostate cancer diagnostics market growth over the forecast period.

Market Segmentation

Global Prostate Cancer Diagnostics Market is segmented into type such as Benign Prostatic Hyperplasia, Prostatic Adenocarcinoma, Small Cell Carcinoma, and Others, by diagnosis, such as Tissue Biopsy, Transrectal Ultrasound, Clinical Laboratory Examination, Urine Testing, and Prostate Specific Antigen Testing. Further, market is segmented into treatment such as Surgery, Radiation Therapy, and Therapeutics (Hormone Therapy, Chemotherapy, and Others).

Also, Global Prostate Cancer Diagnostics Market is segmented five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Market Key Players

Various key players are discussed in this report including Abbott, MDxHealth, Genomic Health, 3D Signatures, OPKO Health, INC., Siemens Healthcare GmbH, DiaSorin S.p.A, F. Hoffman La Roche Ltd., BioMerieux SA, Beckman Coulter, INC., and Myriad Genetic Inc.

Market Taxonomy

By Type
  • Benign Prostatic Hyperplasia
  • Prostatic Adenocarcinoma
  • Small Cell Carcinoma
  • Others
By Diagnosis
  • Tissue Biopsy
  • Transrectal Ultrasound
  • Clinical Laboratory Examination
  • Urine Testing
  • Prostate Specific Antigen Testing
By Treatment
  • Surgery
  • Radiation Therapy
  • Therapeutics
 Hormone Therapy

 Chemotherapy

 Others

By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa
Key Questions Addressed by the Report
  • What are the Key Opportunities in Global Prostate Cancer Diagnostics Market?
  • What will be the growth rate from 2019 to 2027?
  • Which segment/region will have highest growth?
  • What are the factors that will impact/drive the Market?
  • What is the competitive Landscape in the Industry?
  • What is the role of key players in the value chain?
  • What are the strategies adopted by key players?

Table of Contents

189 Pages
1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Prostate Cancer Diagnostics Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Prostate Cancer Diagnostics Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Global Prostate Cancer Diagnostics Market Share Analysis, By Type
5.3 Global Prostate Cancer Diagnostics Market Size and Forecast, By Type
5.3.1 Benign Prostatic Hyperplasia
5.3.2 Prostatic Adenocarcinoma
5.3.3 Small Cell Carcinoma
5.3.4 Others
6 Global Prostate Cancer Diagnostics Market, By Diagnosis
6.1 Y-o-Y Growth Comparison, By Diagnosis
6.2 Global Prostate Cancer Diagnostics Market Share Analysis, By Diagnosis
6.3 Global Prostate Cancer Diagnostics Market Size and Forecast, By Diagnosis
6.3.1 Tissue Biopsy
6.3.2 Transrectal Ultrasound
6.3.3 Clinical Laboratory Examination
6.3.4 Urine Testing
6.3.5 Prostate Specific Antigen Testing
7 Global Prostate Cancer Diagnostics Market, By Treatment
7.1 Y-o-Y Growth Comparison, By Treatment
7.2 Global Prostate Cancer Diagnostics Market Share Analysis, By Treatment
7.3 Global Prostate Cancer Diagnostics Market Size and Forecast, By Treatment
7.3.1 Surgery
7.3.2 Radiation Therapy
7.3.3 Therapeutics
7.3.3.1 Hormone Therapy
7.3.3.2 Chemotherapy
7.3.3.3 Others
8 Global Prostate Cancer Diagnostics Market, By Region
8.1 Global Prostate Cancer Diagnostics Market Share Analysis, By Region
8.2 Global Prostate Cancer Diagnostics Market Share Analysis, By Region
8.3 Global Prostate Cancer Diagnostics Market Size and Forecast, By Region
9 North America Prostate Cancer Diagnostics Market Analysis and Forecast (2020-2027)
9.1 Introduction
9.2 North America Prostate Cancer Diagnostics Market Share Analysis, By Type
9.3 North America Prostate Cancer Diagnostics Market Size and Forecast, By Diagnosis
9.4 North America Prostate Cancer Diagnostics Market Size and Forecast, By Treatment
9.5 North America Prostate Cancer Diagnostics Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 EuropeProstate Cancer Diagnostics Market Analysis and Forecast (2020-2027)
10.1 Introduction
10.2 Europe Prostate Cancer Diagnostics Market Share Analysis, By Type
10.3 Europe Prostate Cancer Diagnostics Market Size and Forecast, By Diagnosis
10.4 Europe Prostate Cancer Diagnostics Market Size and Forecast, By Treatment
10.5 Europe Prostate Cancer Diagnostics Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4 Rest of Europe
11 Asia Pacific Prostate Cancer Diagnostics Market Analysis and Forecast (2020-2027)
11.1 Introduction
11.2 Asia Pacific Prostate Cancer Diagnostics Market Share Analysis, By Type
11.3 Asia Pacific Prostate Cancer Diagnostics Market Size and Forecast, By Diagnosis
11.4 Asia Pacific Prostate Cancer Diagnostics Market Size and Forecast, By Treatment
11.5 Asia Pacific Prostate Cancer Diagnostics Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4 Rest of Asia Pacific
12 Latin America Prostate Cancer Diagnostics Market Analysis and Forecast (2020-2027)
12.1 Introduction
12.2 Latin America Prostate Cancer Diagnostics Market Share Analysis, By Type
12.3 Latin America Prostate Cancer Diagnostics Market Size and Forecast, By Diagnosis
12.4 Latin America Prostate Cancer Diagnostics Market Size and Forecast, By Treatment
12.5 Latin America Prostate Cancer Diagnostics Market Size and Forecast, Country
13 Middle East Prostate Cancer Diagnostics Market Analysis and Forecast (2020-2027)
13.1 Introduction
13.2 Middle East Prostate Cancer Diagnostics Market Share Analysis, By Type
13.3 Middle East Prostate Cancer Diagnostics Market Size and Forecast, By Diagnosis
13.4 Middle East Prostate Cancer Diagnostics Market Size and Forecast, By Treatment
13.5 Middle East Prostate Cancer Diagnostics Market Size and Forecast, By Country
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Abbott
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 MDxHealth
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Genomic Health
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 3 D Signatures
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 OPKO Health, INC
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Siemens Healthcare GmbH
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 DiaSorin S.p.A, F.
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Hoffman La Roche Ltd
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 BioMerieux SA
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Beckman Coulter, INC
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
15.11 Myriad Genetic Inc
15.11.1 Overview
15.11.2 Offerings
15.11.3 Key Financials
15.11.4 Business Segment & Geographic Overview
15.11.5 Key Market Developments
15.11.6 Key Strategies

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us